Gamma-hydroxybutyric acid and its relevance in neurology.
Benarroch
Eduardo E
EE
Mayo Clinic, 200 First Street SW, West 8A Mayo Bldg, Rochester, MN 55905, USA. benarroch.eduardo@mayo.edu
D000437:Alcoholism / Q000188:drug therapy; D001921:Brain / Q000378:metabolism; D006801:Humans; D006885:Hydroxybutyrates / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D009290:Narcolepsy / Q000188:drug therapy; D009422:Nervous System Diseases / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism; D009462:Neurology; D018696:Neuroprotective Agents / Q000627:therapeutic use; D019966:Substance-Related Disorders / Q000209:etiology; D050644:Succinate-Semialdehyde Dehydrogenase / Q000172:deficiency
D006885:Hydroxybutyrates; D018696:Neuroprotective Agents; C111420:4-hydroxybutyric acid; C493643:ALDH5A1 protein, human; D050644:Succinate-Semialdehyde Dehydrogenase